Cencora, Inc. (COR): Total Assets

Annual figures by period end, from SEC filings.

$76.59B
As of 2025-09-30
$83.81B
As of 2026-06-30
+10.6%
3-year compound annual growth
+11.6%
5-year compound annual growth
+10.6%
10-year compound annual growth
2008-09-30: $12.22B2009-09-30: $13.57B2010-09-30: $14.43B2011-09-30: $14.98B2012-09-30: $15.44B2013-09-30: $18.92B2014-09-30: $21.53B2015-09-30: $27.96B2016-09-30: $33.64B2017-09-30: $35.32B2018-09-30: $37.67B2019-09-30: $39.17B2020-09-30: $44.27B2021-09-30: $57.34B2022-09-30: $56.56B2023-09-30: $62.56B2024-09-30: $67.10B2025-09-30: $76.59B$76.59B
2008-09-30 Total Assets (USD) 2025-09-30
Period endedTotal AssetsChange YoYSource filing
2025-09-30$76.59B+14.1%2025-11-25, Balance as of period end
2024-09-30$67.10B+7.3%2025-11-25, Balance as of period end
2023-09-30$62.56B+10.6%2024-11-26, Balance as of period end
2022-09-30$56.56B-1.4%2023-11-21, Balance as of period end
2021-09-30$57.34B+29.5%2022-11-22, Balance as of period end
2020-09-30$44.27B+13.0%2021-11-23, Balance as of period end
2019-09-30$39.17B+4.0%2020-11-19, Balance as of period end
2018-09-30$37.67B+6.7%2019-11-19, Balance as of period end
2017-09-30$35.32B+5.0%2019-11-19, Balance as of period end
2016-09-30$33.64B+20.3%2018-11-20, Balance as of period end
2015-09-30$27.96B+29.9%2017-11-21, Balance as of period end
2014-09-30$21.53B+13.8%2015-11-24, Balance as of period end
2013-09-30$18.92B+22.5%2014-11-25, Balance as of period end
2012-09-30$15.44B+3.1%2013-11-26, Balance as of period end
2011-09-30$14.98B+3.8%2012-11-27, Balance as of period end
2010-09-30$14.43B+6.4%2011-11-22, Balance as of period end
2009-09-30$13.57B+11.1%2010-11-23, Balance as of period end
2008-09-30$12.22Bn/a2009-11-25, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Cencora, Inc. (COR)2025-09-30$76.59B+14.1%
McKesson Corp (MCK)2026-03-31$82.32B+9.6%
Cardinal Health Inc (CAH)2026-06-30$57.30B+7.9%
Herbalife Ltd. (HLF)2025-12-31$2.79B+2.1%
Nu Skin Enterprises, Inc. (NUS)2025-12-31$1.41B-4.3%
Cosmos Health Inc. (COSM)2025-12-31$65.48M+20.6%
DataMeds AI, Inc. (MEDS)2025-12-31$30.46M-46.9%
Stemtech Corp (STEK)2025-12-31$3.15M-16.7%
HWH International Inc. (ESYN)2025-12-31$4.57M-28.7%

Compare COR, MCK, CAH, HLF side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗